Association study between high and low activity polymorphism of catechol-O-methyltransferase gene and alcoholism

Psychiatric Genetics

Volumn 9, Issue 3, 1999, Pages 135-138

  Ishiguro, H ^a   Shibuya, T Haruo ^b   Toru, M ^b   Saito, T ^c   Arinami, T ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b University Sapporo   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Alcoholism; Association; COMT; Polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; AGED; ALCOHOLISM; ANTISOCIAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033380102     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-199909000-00004     Document Type: Article

References (18)

1. Axelrod J, Tomchick R (1958). Enzymic O-methylation of epinephrine and other catechols. J Biol Chem 233:702-705.
2. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:9991-9996.
3. Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin R et al. (1997). Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder [see comments]. Am J Psychiatry 154:113-115.
4. Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, al-Chalabi A et al. (1996). No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochem Biophys Res Comm 228:780-784.
5. Jönsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M et al. (1997). Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247:297-302.
6. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J et al. (1997). Genotype determining low catechol- O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572-4575.
7. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE et al. (1998). Identification of sequence variants and analysis of the role of the catechol-O-methyltransferase gene in schizophrenia susceptibility. Biol Psychiatry 43:425-431.
8. Karoum F, Chrapusta SJ, Egan MF (1994). 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two-pool model. J Neurochem 63:972-979.
9. Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, Hoda F et al. (1997). High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci Lett 221:202-204.
10. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J (1998). Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155:835-837.
11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumianski CL, Weinshilboum RM (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
12. Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I (1995). Cloning, expression and structure of catechol-O-methyltransferase. Biochem Biophys Acta 1251:1-10.
13. Napolitano A, Cesura AM, Da Prada M (1995). The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. J Neural Transm 45:35-45.
14. Ohara K, Nagai M, Suzuki Y (1998). Low activity allele of catechol-O-methyltransferase gene and Japanese unipolar depression. Neuroreport 9:1305-1308.
15. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM (1997). Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69:71-77.
16. Uhl G, Blum K, Noble E, Smith S (1993). Substance abuse vulnerability and D2 receptor genes. Trends Neurosci 16:83-88.
17. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhi GR, Lachman HM (1997). High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74:439-442.
18. Wise RA, Rompre PP (1989). Brain dopamine and reward. Ann Rev Psychol 40:191-225.